Infarmed publishes report on the evolution of medical cannabis activity in Portugal

O infarmed — Autoridade Nacional do Medicamento e Produtos de Saúde IP published an analysis of the activities carried out in the medical cannabis sector in Portugal in the last four years (until June 2022).

The document was first handed over to Cannareporter by Vasco Bettencourt, director of Infarmed Licensing Unit, and takes stock of the various aspects of the sector: licensing, exports, prescriptions and ACM requests, among others.

Entitled “Medical Cannabis — Evolution and Activity”, the document reveals the numbers that indicate that Portugal is a country where cannabis will continue to flourish. More than 100 companies have already started the licensing process.

In 2018, when the Portuguese Parliament approved cannabis for medicinal purposes, the cannabis industry had just taken its first steps in Portugal. Today, it is an industry that moves millions and the prospects seem to be for growth at all levels.

According to the report published by the Inspection and Licensing Directorate of Infarmed, to which Cannareporter had access today, first-hand, the Portuguese medical cannabis industry has been consolidating in Portugal and the number of licensed companies can more than to double in the coming years.

The report “Medical Cannabis — Evolution and Activity” takes stock of the evolution of activities related to the field of cannabis for medicinal purposes in Portugal, with data up to June 2022. The document describes the indicators relating to the number of entities and the global number of requests, as well as a grid with the quantification of documentary suitability decisions (pre-licence) and of authorizations issued (final license) for the exercise of cultivation, manufacturing, distribution, import, export or other purposes specific (such as research).

Key highlights of Infarmed's analysis include:

• number of licenses and pre-licenses assigned;
• global quantities exported and recipient countries;
• number of applications for Marketing Authorizations (ACM);
• number of packages prescribed in Portugal;
• response to requests for information.

Cannareporter will analyze the data from this study in more detail over the next few days. The full report can be viewed below.

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Laura Ramos

More posts Bio

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

• Laura Ramos

  https://cannareporter.eu/author/partner/

  Cannabis Europa returns to Paris on February 19th, at a crucial moment for the sector in France.
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Michael Sassano: "Approvals can be better streamlined and keep the same rigorous quality standards."
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Infarmed grants three ACMs to SOMAÍ's first medicinal cannabis products in Portugal
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Portugal has already spent more than 3 million euros on Epidyolex. Infarmed has been evaluating reimbursement for almost 4 years.

Antonio João Costa

More posts Bio

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu

• Antonio João Costa

  https://cannareporter.eu/author/cannareporter/

  Brazil: Anvisa bans CBD purchased from Paraguay by the São Paulo Public Administration; Public Prosecutor's Office investigates.
• Antonio João Costa

  https://cannareporter.eu/author/cannareporter/

  Spain includes medicinal cannabis magistral preparations in the National Formulary
• Antonio João Costa

  https://cannareporter.eu/author/cannareporter/

  Spain: Study reveals promising effects of CBD (cannabidiol) in controlling alcoholism.
• Antonio João Costa

  https://cannareporter.eu/author/cannareporter/

  Portugal has already spent more than 3 million euros on Epidyolex. Infarmed has been evaluating reimbursement for almost 4 years.